Peer-reviewedCC BY-NC-NDTranslational cancer research
Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study
- 1Clinical Medical School , Shanghai General Hospital of Nanjing Medical University , Shanghai , ;
- 2Department of General Surgery , Shanghai General Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai ,
Related
- Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma
- Development and internal validation of a clinical-MRI nomogram for predicting lymph node metastasis in rectal adenocarcinoma.
- Development and internal validation of a prognostic model for predicting periodontitis progression using clinical and behavioural factors
- Development and internal validation of a clinicopathological and CT radiomics based prediction model for extracranial distant metastasis after radical resection in early-stage non-small cell lung cancer
- Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study
BibTeX
@article{zhang2026development,
title = {{Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study}},
author = {Lei Zhang and Peng Gu and Wentao Ding and Wenting Zhu and Ruitao Wang and Wei Wang and Xing Sun},
journal = {Translational cancer research},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13743221},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study
AU - Lei Zhang
AU - Peng Gu
AU - Wentao Ding
AU - Wenting Zhu
AU - Ruitao Wang
AU - Wei Wang
AU - Xing Sun
PY - 2026
DA - 2026/09/29
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13743221
SN - 2218-676X
ER -